Readers worry that fraud may tarnish the field and slow the race for a cure. Also: Charles Blow’s farewell; treatment for ...
In a novel theory, scientists at Arizona State University's Biodesign Institute propose a unifying explanation for the ...
A research team has discovered that the two key pathological hallmarks of Alzheimer's -- tau protein and beta-amyloid -- affect brain circuits in distinct yet synergistic ways, particularly those ...
A research team from the Institut de Neurociències of the Universitat Autònoma de Barcelona (INc-UAB) has discovered that the two key pathological hallmarks of Alzheimer's—tau protein and beta-amyloid ...
Scientists are testing an experimental anti-amyloid antibody in people expected to develop early-onset Alzheimer's.
HOUSTON - Coya Therapeutics, Inc. (NASDAQ: COYA), a $109.1 million market cap biotechnology company focusing on regulatory T ...
As Valentine's Day approaches, experts say that love might hold the key to a longer, healthier life. Uncover the unexpected ...
Understand Alzheimer's disease Alzheimer's disease is the leading cause of dementia, accounting for approximately 80% of dementia cases and affecting more than 5.5 million people in the United States.